Patent protection for technical products expires after 20 years. However, there is no rule without exception. In its recent decision "Femur-Teil"(judgement of 15 April 2010, I ZR 145/08), the German…
Under Spanish law, when the first generic version of a medicament of reference (i.e. original medicament) is authorized, the setting of the price of the generic triggers the inclusion of the…
Denmark, as one of only a very few countries in the Western world, has no specialty patents court(s) for first instance PI proceedings.
Instead, an application for a PI is heard by the bailiff's…
As previously reported, the Patents County Court was re-launched on 1 October 2010 under the auspices of His Honour Judge Birss QC. The issue of transferring proceedings between the Patents Court of…
The Court of Appeal upheld the High Court's finding that Novartis' patent for ophthalmically compatible extended wear contact lenses was invalid for insufficiency. The Court of Appeal held that the…
The Court of Appeal confirmed the First Instance Court decision and held that Occlutech's devices do not infringe AGA's patent regarding septal occlusion devices, which feature braided metal strands…
The District Court of The Hague declares the Dutch part of Bayer's European Patent covering Anti-TNF alpha human monoclonal antibodies invalid. The Court considers that the patent covers high…
The Thessaloniki Court of Appeal held in nullity proceedings that the patent, covering ornamental light devices, lacked both novelty and inventive step. The patented subject matter was found to be…
The new French law implementing the London Protocol is immediately applicable, even to European patents granted before the entry into force of this new law. The Court held that the new law was…
The Enlarged Board of Appeal answered the question referred to it by the Board of Appeal in J 2/08.
The Enlarged Board of Appeal held that after a decision to refuse a European patent application,…
